What Happened?
, -based Immunocore Appointed John Goll as SVP, Finance and Chief Accounting Officer
About the Company
Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.
About the Person
John Goll is SVP, Finance and Chief Accounting Officer at Immunocore. Previously, John held various senior HR leadership roles in the industry.
Info Source
News
Short Profile